A detailed history of Signaturefd, LLC transactions in Merus N.V. stock. As of the latest transaction made, Signaturefd, LLC holds 1,114 shares of MRUS stock, worth $52,569. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,114
Previous 1,139 2.19%
Holding current value
$52,569
Previous $51,000 27.45%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$39.81 - $60.2 $995 - $1,505
-25 Reduced 2.19%
1,114 $65,000
Q2 2023

Aug 01, 2023

SELL
$18.33 - $27.18 $2,162 - $3,207
-118 Reduced 9.39%
1,139 $29,000
Q1 2023

Apr 28, 2023

BUY
$14.25 - $20.5 $16,587 - $23,862
1,164 Added 1251.61%
1,257 $23,000
Q4 2022

Jan 27, 2023

BUY
$12.8 - $23.66 $1,190 - $2,200
93 New
93 $1,000

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.16B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.